Name: ZJYL Income Statement - Jin Medical International Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ZJYL - Jin Medical International Ltd.

USD | NASDAQ | Healthcare

ZJYL Income Statement - Jin Medical International Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues
Revenues	20.7	23.5	19.8	19.2	20.8
Cost of Revenue	14.6	14.0	13.0	13.0	14.4
Gross Profit	6.0	9.5	6.8	6.2	6.4
Operating Expenses
Research & Development	1.6	1.5	1.5	1.9	1.6
Selling General & Administrative	-	-	-	-	-
Selling & Marketing	-
Operating Income
Operating Income	0.6	3.6	2.9	2.1	2.6
Non-Operating
Interest Income	0.8	0.5	0.1	0.1	0.1
Interest Expense	-	-	-	-	-
Income From Equity Investments	-	-
Tax & Net
Income Tax Expense	0.2	0.8	0.3	0.0	0.2
Net Income From Continuing Ops	1.4	3.4	2.9	2.7	2.6
Net Income From Discontinued Ops	-
Per Share
EPS Basic	0.01	0.02	0.02	0.02	0.02
EPS Diluted	0.01	0.02	0.02	0.02	0.02
Shares Basic	156.5	156.5
Supplementary Data
EBITDA	0.9	3.9	3.1	2.5	3.0
EBIT	0.6	3.6	2.9	2.1	2.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)